Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

计划入组 215 人 · 首次发布于 2025 年 5 月 9 日

BIONICS Israel Trial

计划入组 58 人 · 首次发布于 2016 年 7 月 15 日

Venue Ultrasound Evaluation - Israel

计划入组 53 人 · 首次发布于 2019 年 3 月 4 日

scFv-F240 (Beth Israel)

CLK1/4 kinase inhibitor (Beth Israel Deaconess Medical Center/Boston Children's Hospital)

LTD-23

Medgenics Medical (Israel) Ltd.

Israel

Kalytera Therapeutics Israel, Ltd.

Anchiano Therapeutics Israel Ltd.

Israel

Beyond Air to Sell NeuroNOS Stake to UNIVO in Exchange for Equity and Up to $32.5 Million in Milestone Payments

XTL Biopharmaceuticals Acquires 85% of NeuroNOS in $32.5M Deal to Target Autism Therapeutics Market

FDA Grants Orphan Drug Designation to NeuroNOS for Phelan-McDermid Syndrome Treatment